HALEY TIPPS: Open Payments
NPI 1841766375 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,048 in 142 payments from 43 companies in 2025. Trend: 2023 $2,900 · 2024 $2,754 · 2025 $3,048
Food & beverage: $2,850Education: $198
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $462 |
| Novartis Pharmaceuticals Corporation | 12 | $243 |
| Incyte Corporation | 5 | $166 |
| Genentech USA, Inc. | 7 | $151 |
| Janssen Biotech, Inc. | 9 | $148 |
| Daiichi Sankyo Inc. | 10 | $147 |
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| SEAGEN INC. | 1 | $99 |
| PFIZER INC. | 7 | $88 |
Products named: IMFINZI, Enhertu, OPDIVO, KEYTRUDA, Venclexta, Somatuline Depot, KISQALI, SARCLISA.
Industry payments across AL — which companies pay providers there.
